Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

Market Cap	15.69B
Revenue (ttm)	5.13B
Net Income (ttm)	882.00M
Shares Out	663.61M
EPS (ttm)	1.33
PE Ratio	17.77
Forward PE	14.01
Dividend	0.60 (2.56%)
Ex-Dividend Date	Oct 11, 2024

Volume	9,722,740
Average Volume	10,138,987
Open	23.65
Previous Close	23.64
Day's Range	23.54 - 23.83
52-Week Range	21.64 - 32.33
Beta	0.51
RSI	44.66
Earnings Date	Apr 29, 2025

About SHA:600529

Shandong Pharmaceutical Glass Co.Ltd manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. It offers pharma glass packaging products, such as molded injection glass vials, food-grade bottles, clear cosmetic bottles, cobalt blue and green bottles, tubular glass vials, ampoules, glass tubing products, amber glass bottles, and other borosilicate glass products; butyl rubber stoppers; prefilled syringes, plastic and aluminum caps, plastic caps, and plastic bottles; and dropper caps and Teflon coated rubber...

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1970
• Employees: 6,473
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600529

Financial Performance

In 2023, SHA:600529's revenue was 4.98 billion, an increase of 18.98% compared to the previous year's 4.19 billion. Earnings were 775.80 million, an increase of 25.48%.